Search research articles
Contact Us
Filters
Showing results (221-230 of 231) with videos related to
Page
of 24
Sort By:
Biorxiv : the Preprint Server for Biology
|
August 15, 2020
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
Markus Hoffmann, Heike Hofmann-Winkler, Joan C Smith, et al.
The Journal of Clinical Investigation
|
April 4, 2018
Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation
Thomas Vogl, Athanasios Stratis, Viktor Wixler, et al.
Ebiomedicine
|
March 7, 2021
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
Markus Hoffmann, Heike Hofmann-Winkler, Joan C Smith, et al.
Cells
|
February 25, 2023
Pathophysiological Mechanisms of Cardiac Dysfunction in Transgenic Mice with Viral Myocarditis
Matthias Rohrbeck, Verena Hoerr, Ilaria Piccini, et al.
Pharmacological Research
|
November 10, 2020
Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection
Eliza M Melo, Juliana Del Sarto, Juliana P Vago, et al.
Antiviral Research
|
November 24, 2022
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier
Aileen Faist, Sebastian Schloer, Angeles Mecate-Zambrano, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 8, 2022
Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection
Jonas Schuhenn, Toni Luise Meister, Daniel Todt, et al.
Nature Communications
|
March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
Federico Bertoglio, Doris Meier, Nora Langreder, et al.
Nature Communications
|
May 19, 2023
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients
Felix Dewald, Martin Pirkl, Martha Paluschinski, et al.
Science Immunology
|
April 17, 2026
Divergent granulopoiesis at extramedullary sites safeguards antibacterial host defense
Carlos Silvestre-Roig, Raphael Chevre, Merieme Farjia, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 231) with videos related to
Sort By:
Page
of 24
Biorxiv : the Preprint Server for Biology
|
August 15, 2020
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
Markus Hoffmann, Heike Hofmann-Winkler, Joan C Smith, et al.
The Journal of Clinical Investigation
|
April 4, 2018
Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation
Thomas Vogl, Athanasios Stratis, Viktor Wixler, et al.
Ebiomedicine
|
March 7, 2021
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
Markus Hoffmann, Heike Hofmann-Winkler, Joan C Smith, et al.
Cells
|
February 25, 2023
Pathophysiological Mechanisms of Cardiac Dysfunction in Transgenic Mice with Viral Myocarditis
Matthias Rohrbeck, Verena Hoerr, Ilaria Piccini, et al.
Pharmacological Research
|
November 10, 2020
Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection
Eliza M Melo, Juliana Del Sarto, Juliana P Vago, et al.
Antiviral Research
|
November 24, 2022
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier
Aileen Faist, Sebastian Schloer, Angeles Mecate-Zambrano, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 8, 2022
Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection
Jonas Schuhenn, Toni Luise Meister, Daniel Todt, et al.
Nature Communications
|
March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
Federico Bertoglio, Doris Meier, Nora Langreder, et al.
Nature Communications
|
May 19, 2023
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients
Felix Dewald, Martin Pirkl, Martha Paluschinski, et al.
Science Immunology
|
April 17, 2026
Divergent granulopoiesis at extramedullary sites safeguards antibacterial host defense
Carlos Silvestre-Roig, Raphael Chevre, Merieme Farjia, et al.
Page
of 24